Hilltop Holdings Inc. Has $12.32 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Hilltop Holdings Inc. raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 205.1% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,069 shares of the healthcare conglomerate’s stock after acquiring an additional 14,163 shares during the quarter. UnitedHealth Group comprises approximately 0.8% of Hilltop Holdings Inc.’s investment portfolio, making the stock its 16th biggest holding. Hilltop Holdings Inc.’s holdings in UnitedHealth Group were worth $12,318,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Delta Financial Group Inc. boosted its holdings in UnitedHealth Group by 1.0% in the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock valued at $965,000 after acquiring an additional 17 shares during the last quarter. Signature Resources Capital Management LLC raised its stake in UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after buying an additional 18 shares during the last quarter. Saxony Capital Management LLC grew its holdings in UnitedHealth Group by 3.5% during the 2nd quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock worth $270,000 after acquiring an additional 18 shares during the period. GoalVest Advisory LLC boosted its position in shares of UnitedHealth Group by 0.6% during the 2nd quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock valued at $1,591,000 after purchasing an additional 18 shares in the last quarter. Finally, Fiduciary Group LLC increased its holdings in UnitedHealth Group by 0.5% in the second quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock worth $1,882,000 after purchasing an additional 18 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have recently commented on the stock. UBS Group reduced their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Truist Financial reiterated a “buy” rating and set a $625.00 price objective (down previously from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Cantor Fitzgerald boosted their target price on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research report on Wednesday, October 16th. Bank of America reduced their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Finally, Hsbc Global Res downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. Four equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $618.26.

UnitedHealth Group Price Performance

UNH opened at $611.50 on Monday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The firm has a market cap of $562.75 billion, a P/E ratio of 39.75, a PEG ratio of 1.79 and a beta of 0.58. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The firm has a 50-day moving average of $585.43 and a 200 day moving average of $556.65.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same period last year, the business posted $6.56 earnings per share. The business’s revenue for the quarter was up 9.2% on a year-over-year basis. On average, research analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be issued a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.37%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.